Gliosis is the rule rather than the exception in the organization of an MS plaque, and therefore, GFAP and protein S-100B were examined in the CSF in patients with MS.[62] CSF levels of GFAP and S100B were elevated in patients with relapsing as well as progressive disease. This evidence concerns the gene GFAP and myeloid sarcoma.